Dekabank Deutsche Girozentrale / LLY
Dekabank Deutsche Girozentrale’s Eli Lilly & Co Position
Does Dekabank Deutsche Girozentrale own Eli Lilly & Co (LLY)? Yes — 915.4K shares worth $848M (+1.40% of its 13F portfolio) as of Q1 2026.
Position Value
$848M
Q1 2026
Shares
915.4K
% of Portfolio
+1.40%
Quarters Held
29
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 915.4K | $848M | +1.40% |
| Q4 2025 | 915.4K | $746M | +1.29% |
| Q3 2025 | 915.4K | $664M | +1.12% |
| Q2 2025 | 915.4K | $714M | +1.27% |
| Q1 2025 | 911.1K | $741M | +1.45% |
| Q4 2024 | 915.4K | $710M | +1.31% |
| Q3 2024 | 915.4K | $790M | +1.46% |
| Q2 2024 | 917.2K | $839M | +1.51% |
| Q1 2024 | 911.1K | $709M | +1.32% |
| Q4 2023 | 884.9K | $515M | +1.06% |
| Q3 2023 | 891.8K | $486M | +1.12% |
| Q2 2023 | 762.6K | $358M | +0.80% |
| Q1 2023 | 751.8K | $255M | +0.64% |
| Q4 2022 | 721.3K | $263M | +0.70% |
| Q3 2022 | 651.6K | $216M | +0.64% |
| Q2 2022 | 632.1K | $203M | +0.59% |
| Q1 2022 | 624.8K | $181M | +0.44% |
| Q4 2021 | 672.3K | $187M | +0.46% |
| Q3 2021 | 627.1K | $144M | +0.40% |
| Q2 2021 | 557.1K | $128M | +0.37% |
| Q1 2021 | 658.4K | $122M | +0.41% |
| Q3 2020 | 600.1K | $87M | +0.39% |
| Q2 2020 | 300.5K | $49M | +0.31% |
| Q1 2020 | 298.6K | $42M | +0.32% |
| Q4 2019 | 355.1K | $47M | +0.29% |
| Q3 2019 | 619.0K | $70M | +0.43% |
| Q2 2019 | 947.3K | $106M | +0.53% |
| Q1 2019 | 890.2K | $94M | +0.56% |
| Q4 2018 | 759.6K | $86M | +0.57% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of LLY.